retatrutide ly3437943 phase 2 trial obesity nejm 2023 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide just posted the biggest

Tirzepatide is the first combination of entero-pancreatic hormones [dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) RA] that has been approved for T2D management based on the findings from the phase 3 SURPASS programme

Safety profile : Whilst lower doses might theoretically reduce the incidence of dose-dependent adverse effects such as nausea and vomiting, this has not been systematically studied, and the overall risk-benefit ratio remains unknown

Non-Injectable Peptides for Weight Loss: What Actually Exists There are legitimate oral options and there are marketing options, and it helps to separate them

Depending on the weight of the patient, the cost at Skin Renewal varies between R660 and R1?600 per treatment

GLP-1 Travel The Airplane Carry-On Kit for GLP-1 Travelers TLDR: All you need to know TLDR: Your GLP-1 pen goes in your carry-on

doi: 10.3389/fnsyn.2022.955258 Received 28 May 2022 Accepted 06 July 2022 Published 27 July 2022 Volume 14 - 2022 Edited by Niraj S